Capacity expansion underway at our Ambernath facility
We recently announced an investment at our Ambernath facility in India—transforming it into a larger, more diverse site. This expansion is part of PolyPeptide’s strategic growth, alongside our capacity investments in Malmö and Braine-l’Alleud. Together, these initiatives strengthen our position as a leading CDMO partner for complex peptide therapeutics worldwide.
We’re enhancing our development capabilities, diversifying our portfolio, and positioning PolyPeptide as a trusted CDMO partner for complex peptide therapeutics worldwide.
What this means for PolyPetide Ambernath
The transformation of our Ambernath site represents a substantial commitment to our capabilities in India:
Increased Capacity: Production capacity will increase by more than 3x, significantly expanding our ability to serve clients across multiple healthcare segments.
Advanced Infrastructure: The facility will feature cutting-edge technology and enhanced development capabilities, enabling us to tackle increasingly complex peptide synthesis and support innovation in therapeutics.
Multi-Purpose Design: The expanded site will be configured as a multi-purpose facility, allowing us to serve diverse healthcare segments with flexibility and efficiency.
Sustainability Integration: Sustainable practices are being integrated throughout the facility design and operations, reflecting our commitment to responsible manufacturing.
Community Impact: This expansion will create new employment opportunities for local communities, contributing to economic development in the region.
Meeting global demand
This investment reflects our confidence in our team’s capabilities and our commitment to meeting the growing global demand for peptide therapeutics. As we expand our footprint and enhance our technical capabilities, we’re well-positioned to support our clients’ most ambitious projects and continue leading innovation in peptide manufacturing.
Watch Abhijeet Shinde, our Ambernath Site Head, share more about this transformation.